ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14.04	22.41	48.82	363.67	434.22	9.02
Short-Term Investments	143.4	160.33	217.39	0	0	0
Cash & Cash Equivalents	157.44	182.74	266.21	363.67	434.22	9.02
Cash Growth	-30.93%	-31.36%	-26.80%	-16.25%	4715.56%	9.14%
Receivables	0	0	0	0	0	0.54
Other Current Assets	10.43	5.92	4.76	3.35	1.77	0.26
Total Current Assets	167.86	188.66	270.97	367.02	435.99	9.81
Property, Plant & Equipment	3.44	3.59	3.89	0.9	0.05	0.86
Long-Term Investments	27.05	35.41	16.7	0	0	0
Other Long-Term Assets	14.3	14.89	14.93	12.27	0.01	0.01
Total Long-Term Assets	44.79	53.89	35.52	13.16	0.06	0.87
Total Assets	212.65	242.55	306.49	380.18	436.05	10.68
Accounts Payable	6.6	9.13	9.72	5.39	0.08	3.75
Other Current Liabilities	25.63	26.87	18.6	9.9	6.13	1.24
Total Current Liabilities	32.23	36	28.33	15.3	6.2	4.98
Long-Term Debt	9.7	9.64	9.39	0	0	5.42
Other Long-Term Liabilities	6.52	7.2	5.31	1.84	0.01	0.55
Total Long-Term Liabilities	16.23	16.84	14.7	1.84	0.01	5.97
Total Liabilities	48.46	52.84	43.03	17.13	6.21	10.95
Total Debt	9.7	9.64	9.39	0	0	5.42
Debt Growth	2.68%	2.66%	-	-	-	-
Retained Earnings	-521.85	-486.27	-325.47	-201.99	-118.52	-72.78
Comprehensive Income	0.03	0.26	-0.85	0	0	0
Shareholders' Equity	164.2	189.71	263.46	363.05	429.85	-70.64
Net Cash / Debt	147.73	173.1	256.82	363.67	434.22	3.6
Net Cash / Debt Growth	-32.39%	-32.60%	-29.38%	-16.25%	11975.06%	-56.48%
Net Cash Per Share	2.95	4.03	6.31	9.02	23.49	1.17
Working Capital	135.64	152.66	242.64	351.72	429.79	4.83
Book Value Per Share	3.28	4.41	6.47	9.01	23.25	-22.96

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).